Skip to main content

Finance

By HIMSS TV | 11:41 am | June 16, 2025
Anil Soni, CEO of the WHO Foundation, discusses a $3.6 million fundraising initiative, enhanced by a dollar-for-dollar match, to protect the Global Measles and Rubella Laboratory Network, working to control and eliminate both diseases.
By HIMSS TV | 11:53 am | June 11, 2025
Millie founder and CEO Anu Sharma discusses reasons why one-third of the U.S. is considered a "maternity care desert" and what can be done.  
By Jessica Hagen | 02:06 pm | June 06, 2025
Kidd's company will use 1,000 Bitcoin and additional cash to acquire the interest, and the former Ripple chief risk officer will become CEO and chairman of the board.
By Jessica Hagen | 11:30 am | June 06, 2025
The company is offering 7.9 million of its common stock at an initial price of $19 per share, with shares trading under the ticker symbol OMDA.
By HIMSS TV | 12:00 pm | June 05, 2025
Morgan Cheatham, partner and head of healthcare and life sciences at Breyer Capital, provides highlights of the venture capital firm's strategy when funding emerging technologies and the risks associated with backing these innovations.
By Jessica Hagen | 12:47 pm | June 03, 2025
The healthcare engagement company, which focuses on vulnerable populations, acquired the food delivery company, thanks to a $47.5 million investment.
HIMSS25
By HIMSS TV | 12:11 pm | May 30, 2025
As AI technology continues to evolve, Abhinav Shashank, Innovaccer CEO, says IT leaders must stay focused on ensuring that all AI tools are ethically trained, tested and deployed and that their desired outcomes are clearly defined.
HIMSS25
By HIMSS TV | 05:39 pm | May 29, 2025
While they were originally tools for administrative documentation, EHRs now prioritize streamlining clinicians' workflows and enhancing care delivery, says Sandra Johnson, SVP of client services at CliniComp.
By Jessica Hagen | 12:09 pm | May 29, 2025
The company plans to offer an aggregate of 7.9 million shares of its common stock with an initial public offering price between $18 and $20 per share.
By Anthony Vecchione | 03:36 pm | May 27, 2025
The company will use the funds to grow its team, expedite commercial deployments with pharma companies and enhance Willis, its new clinical outcome assessment platform.